publication . Article . 2015

Global policy and access to new hepatitis C therapies for people who inject drugs

Sharon Hutchinson;
Open Access
  • Published: 05 Jun 2015 Journal: International Journal of Drug Policy, volume 26, pages 1,064-1,071 (issn: 0955-3959, Copyright policy)
  • Publisher: Elsevier BV
Abstract
Abstract People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV). This review outlines policy recommendations made in the 2014 World Health Organisation (WHO) Guidelines on Screening, Care and Treatment of HCV and their relevance to PWID. It also canvasses issues that will affect translation of these global guidelines into practice. The first global HCV guidelines released by WHO have recently advocated targeted HCV testing for PWID, assessment of liver disease and support for alcohol reduction during care. They also strongly advocate treatment using currently licensed direct-acting antiviral agents for all individuals, in parti...
Subjects
free text keywords: Health Policy, Medicine (miscellaneous)
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue